RECRUITING

Community Support Program for Lung Cancer Screening Volume II

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a West Philadelphia based community project to improve adherence to lung cancer screening. The overall objective of this project is to demonstrate the impact of a community support program (CSP) on improve adherence to LCS follow-up guidelines in an urban environment. The study will target individuals in the Penn Medicine healthcare system residing in Philadelphia with an upcoming or missed follow-up screening or orders placed but who have not yet scheduled their screenings by offering free transportation coordination to and from the appointment. The study team will also offer to connect those with placed but unscheduled low dose CT orders to connect with Penn Medicine's scheduling staff.

Official Title

Community Support Program for Lung Cancer Screening Volume II

Quick Facts

Study Start:2024-10-01
Study Completion:2025-04-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06628167

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 89 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Upcoming or missed low dose CT for lung cancer screening
  2. * Philadelphia resident
  1. * Lives outside Philadelphia city limits

Contacts and Locations

Study Contact

Farouk Dako
CONTACT
2673091241
farouk.dako@pennmedicine.upenn.edu
Caroline Rosen
CONTACT
caroline.rosen@pennmedicine.upenn.edu

Principal Investigator

Farouk Dako, MD
PRINCIPAL_INVESTIGATOR
farouk.dako@pennmedicine.upenn.edu

Study Locations (Sites)

Univeristy of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: Abramson Cancer Center at Penn Medicine

  • Farouk Dako, MD, PRINCIPAL_INVESTIGATOR, farouk.dako@pennmedicine.upenn.edu

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-01
Study Completion Date2025-04-08

Study Record Updates

Study Start Date2024-10-01
Study Completion Date2025-04-08

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Cancer